Skip to main content
. Author manuscript; available in PMC: 2021 Sep 30.
Published in final edited form as: Ann Surg Oncol. 2011 Dec 1;19(5):1663–1669. doi: 10.1245/s10434-011-2156-7

TABLE 2.

Neoadjuvant therapy

Characteristic Number (%)
Neoadjuvant radiation
 Yes 21 (58.3)
 No 15 (41.7)
Chemotherapy
 Gemcitabine 11 (30.5)
 Gemcitabine ? taxotere ? xeloda 11 (30.5)
 Gemcitabine ? xeloda 4 (11.1)
 Gemcitabine ? 5-FU ? leukovorin 4 (11.1)
 Gemcitabine ? erlotinib 3 (8.3)
 Gemcitabine ? cisplatin 2 (5.6)
 5-FU ? leukovorin 2 (5.6)
 Gemcitabine ? oxaliplatin 1 (2.8)
 Gemcitabine ? carboplatin 1 (2.8)